{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:44:52Z","timestamp":1794926692298,"version":"4.9.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous studies found intestinal microbiota alterations which are thought to affect the development of various diseases through the production of gut-derived metabolites. However, the specific metabolites and their pathophysiological contribution to cardiac hypertrophy or heart failure progression still remain unclear. N,N,N-trimethyl-5-aminovaleric acid (TMAVA), derived from trimethyllysine through the gut microbiota, was elevated with gradually increased risk of cardiac mortality and transplantation in a prospective heart failure cohort (<jats:italic>n<\/jats:italic>\u2009=\u20091647). TMAVA treatment aggravated cardiac hypertrophy and dysfunction in high-fat diet-fed mice. Decreased fatty acid oxidation (FAO) is a hallmark of metabolic reprogramming in the diseased heart and contributes to impaired myocardial energetics and contractile dysfunction. Proteomics uncovered that TMAVA disturbed cardiac energy metabolism, leading to inhibition of FAO and myocardial lipid accumulation. TMAVA treatment altered mitochondrial ultrastructure, respiration and FAO and inhibited carnitine metabolism. Mice with \u03b3-butyrobetaine hydroxylase (BBOX) deficiency displayed a similar cardiac hypertrophy phenotype, indicating that TMAVA functions through BBOX. Finally, exogenous carnitine supplementation reversed TMAVA induced cardiac hypertrophy. These data suggest that the gut microbiota-derived TMAVA is a key determinant for the development of cardiac hypertrophy through inhibition of carnitine synthesis and subsequent FAO.<\/jats:p>","DOI":"10.1038\/s41467-022-29060-7","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:22:14Z","timestamp":1648808534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy"],"prefix":"10.1038","volume":"13","author":[{"given":"Mingming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9929-8975","authenticated-orcid":false,"given":"Moshi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva T.","family":"Garcia-Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-7825","authenticated-orcid":false,"given":"Y. Eugene","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-9975","authenticated-orcid":false,"given":"Xiangbao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9774-3980","authenticated-orcid":false,"given":"Dao Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4473-6936","authenticated-orcid":false,"given":"Lemin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"29060_CR1","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin, E. J. et al. Heart Disease and Stroke Statistics\u20142018 update: a report from the American Heart Association. Circulation 137, e67\u2013e492 (2018).","journal-title":"Circulation"},{"key":"29060_CR2","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1056\/NEJM199910213411706","volume":"341","author":"JJ Hunter","year":"1999","unstructured":"Hunter, J. J. & Chien, K. R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341, 1276\u20131283 (1999).","journal-title":"N. Engl. J. Med."},{"key":"29060_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","volume":"385","author":"E Braunwald","year":"2015","unstructured":"Braunwald, E. The war against heart failure: the Lancet lecture. Lancet 385, 812\u2013824 (2015).","journal-title":"Lancet"},{"key":"29060_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti, G. J., Yanes, O. & Siuzdak, G. Metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 13, 263 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"29060_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S. & Stanley, W. C. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207\u2013258 (2010).","journal-title":"Physiol. Rev."},{"key":"29060_CR6","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","volume":"94","author":"MN Sack","year":"1996","unstructured":"Sack, M. N. et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94, 2837\u20132842 (1996).","journal-title":"Circulation"},{"key":"29060_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/cvr\/cvn282","volume":"81","author":"M van Bilsen","year":"2009","unstructured":"van Bilsen, M., van Nieuwenhoven, F. A. & van der Vusse, G. J. Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc. Res. 81, 420\u2013428 (2009).","journal-title":"Cardiovasc. Res."},{"key":"29060_CR8","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","volume":"1813","author":"JS Jaswal","year":"2011","unstructured":"Jaswal, J. S., Keung, W., Wang, W., Ussher, J. R. & Lopaschuk, G. D. Targeting fatty acid and carbohydrate oxidation-a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta 1813, 1333\u20131350 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"29060_CR9","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.111.075978","volume":"126","author":"L He","year":"2012","unstructured":"He, L. et al. Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity. Circulation 126, 1705\u20131716 (2012).","journal-title":"Circulation"},{"key":"29060_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/CIRCRESAHA.111.243964","volume":"109","author":"C Riehle","year":"2011","unstructured":"Riehle, C. et al. PGC-1beta deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ. Res. 109, 783\u2013793 (2011).","journal-title":"Circ. Res."},{"key":"29060_CR11","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","volume":"119","author":"J Yan","year":"2009","unstructured":"Yan, J. et al. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119, 2818\u20132828 (2009).","journal-title":"Circulation"},{"key":"29060_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg, I. J., Trent, C. M. & Schulze, P. C. Lipid metabolism and toxicity in the heart. Cell Metab. 15, 805\u2013812 (2012).","journal-title":"Cell Metab."},{"key":"29060_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/CIRCRESAHA.107.160457","volume":"101","author":"LS Szczepaniak","year":"2007","unstructured":"Szczepaniak, L. S., Victor, R. G., Orci, L. & Unger, R. H. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ. Res. 101, 759\u2013767 (2007).","journal-title":"Circ. Res."},{"key":"29060_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1172\/JCI16751","volume":"111","author":"H Yagyu","year":"2003","unstructured":"Yagyu, H. et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Investig. 111, 419\u2013426 (2003).","journal-title":"J. Clin. Investig."},{"key":"29060_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/01.RES.0000154079.20681.B9","volume":"96","author":"H-C Chiu","year":"2005","unstructured":"Chiu, H.-C. et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ. Res. 96, 225\u2013233 (2005).","journal-title":"Circ. Res."},{"key":"29060_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1172\/JCI10947","volume":"107","author":"H-C Chiu","year":"2001","unstructured":"Chiu, H.-C. et al. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Investig. 107, 813\u2013822 (2001).","journal-title":"J. Clin. Investig."},{"key":"29060_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.109.888735","volume":"121","author":"G Duncan Jennifer","year":"2010","unstructured":"Duncan Jennifer, G. et al. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-\u03b1 transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-\u03b1 activators. Circulation 121, 426\u2013435 (2010).","journal-title":"Circulation"},{"key":"29060_CR18","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.echo.2010.09.007","volume":"23","author":"L Ernande","year":"2010","unstructured":"Ernande, L. et al. Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J. Am. Soc. Echocardiogr. 23, 1266\u20131272 (2010).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"29060_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/CIRCULATIONAHA.114.012285","volume":"131","author":"F Liu","year":"2015","unstructured":"Liu, F. et al. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor alpha. Circulation 131, 795\u2013804 (2015).","journal-title":"Circulation"},{"key":"29060_CR20","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","volume":"101","author":"RB Devereux","year":"2000","unstructured":"Devereux, R. B. et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101, 2271\u20132276 (2000).","journal-title":"Circulation"},{"key":"29060_CR21","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1053\/j.gastro.2020.02.033","volume":"158","author":"M Zhao","year":"2020","unstructured":"Zhao, M. et al. TMAVA, a metabolite of intestinal microbes, is increased in plasma from patients with liver steatosis, inhibits \u03b3-butyrobetaine hydroxylase, and exacerbates fatty liver in mice. Gastroenterology 158, 2266\u20132281.e2227 (2020).","journal-title":"Gastroenterology"},{"key":"29060_CR22","doi-asserted-by":"crossref","unstructured":"Li, X. S. et al. Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI insight 3 (2018).","DOI":"10.1172\/jci.insight.99096"},{"key":"29060_CR23","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1093\/eurheartj\/ehz259","volume":"40","author":"XS Li","year":"2019","unstructured":"Li, X. S., et al. Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. Eur. Heart J. 40, 2700\u20132709 (2019).","journal-title":"Eur. Heart J"},{"key":"29060_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18756-2","volume":"8","author":"X Cui","year":"2018","unstructured":"Cui, X. et al. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Sci. Rep. 8, 635 (2018).","journal-title":"Sci. Rep."},{"key":"29060_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35, 904\u2013910 (2014).","journal-title":"Eur. Heart J."},{"key":"29060_CR26","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WH Tang","year":"2014","unstructured":"Tang, W. H. et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908\u20131914 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"29060_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585 (2013).","journal-title":"Nat. Med."},{"key":"29060_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1172\/JCI30400","volume":"117","author":"VT Samuel","year":"2007","unstructured":"Samuel, V. T. et al. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 117, 739\u2013745 (2007).","journal-title":"J. Clin. Invest."},{"key":"29060_CR29","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/j.crohns.2012.08.011","volume":"7","author":"PS Shekhawat","year":"2013","unstructured":"Shekhawat, P. S., Sonne, S., Carter, A. L., Matern, D. & Ganapathy, V. Enzymes involved in L-carnitine biosynthesis are expressed by small intestinal enterocytes in mice: implications for gut health. J. Crohn\u2019s Colitis 7, e197\u2013e205 (2013).","journal-title":"J. Crohn"},{"key":"29060_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/5030","volume":"21","author":"J Nezu","year":"1999","unstructured":"Nezu, J. et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet. 21, 91\u201394 (1999).","journal-title":"Nat. Genet."},{"key":"29060_CR31","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/CIRCULATIONAHA.105.586107","volume":"113","author":"M Grube","year":"2006","unstructured":"Grube, M. et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113, 1114\u20131122 (2006).","journal-title":"Circulation"},{"key":"29060_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0005-2736(77)90257-7","volume":"471","author":"P Molstad","year":"1977","unstructured":"Molstad, P., Bohmer, T. & Eiklid, K. Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in culture. Biochim. Biophys. Acta 471, 296\u2013304 (1977).","journal-title":"Biochim. Biophys. Acta"},{"key":"29060_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31484-5","volume":"8","author":"O Karkkainen","year":"2018","unstructured":"Karkkainen, O. et al. Whole grain intake associated molecule 5-aminovaleric acid betaine decreases beta-oxidation of fatty acids in mouse cardiomyocytes. Sci. Rep. 8, 13036 (2018).","journal-title":"Sci. Rep."},{"key":"29060_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","volume":"4","author":"E Pasini","year":"2016","unstructured":"Pasini, E. et al. Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail. 4, 220\u2013227 (2016).","journal-title":"JACC Heart Fail."},{"key":"29060_CR35","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","volume":"50","author":"A Sandek","year":"2007","unstructured":"Sandek, A. et al. Altered intestinal function in patients with chronic heart failure. J. Am. Coll. Cardiol. 50, 1561\u20131569 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"29060_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jchf.2015.12.004","volume":"4","author":"WH Tang","year":"2016","unstructured":"Tang, W. H. We are not alone: understanding the contributions of intestinal microbial communities and the congested gut in heart failure. JACC Heart Fail. 4, 228\u2013229 (2016).","journal-title":"JACC Heart Fail."},{"key":"29060_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrcardio.2015.200","volume":"13","author":"GB Lim","year":"2016","unstructured":"Lim, G. B. Heart failure: gut flora-pathogenic role in chronic heart failure. Nat. Rev. Cardiol. 13, 61 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"29060_CR38","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","volume":"36","author":"K Damman","year":"2015","unstructured":"Damman, K. & Testani, J. M. The kidney in heart failure: an update. Eur. Heart J. 36, 1437\u20131444 (2015).","journal-title":"Eur. Heart J."},{"key":"29060_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri, N. D. et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83, 308\u2013315 (2013).","journal-title":"Kidney Int."},{"key":"29060_CR40","doi-asserted-by":"publisher","first-page":"e0199274","DOI":"10.1371\/journal.pone.0199274","volume":"14","author":"BL Zybailov","year":"2019","unstructured":"Zybailov, B. L. et al. Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats. PLoS ONE 14, e0199274 (2019).","journal-title":"PLoS ONE"},{"key":"29060_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1681\/ASN.2013080905","volume":"25","author":"A Ramezani","year":"2014","unstructured":"Ramezani, A. & Raj, D. S. The gut microbiome, kidney disease, and targeted interventions. J. Am. Soc. Nephrol. 25, 657\u2013670 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"29060_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000353764","volume":"38","author":"ND Vaziri","year":"2013","unstructured":"Vaziri, N. D., Yuan, J., Nazertehrani, S., Ni, Z. & Liu, S. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am. J. Nephrol. 38, 99\u2013103 (2013).","journal-title":"Am. J. Nephrol."},{"key":"29060_CR43","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.amjcard.2009.06.063","volume":"104","author":"ACT Ng","year":"2009","unstructured":"Ng, A. C. T. et al. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am. J. Cardiol. 104, 1398\u20131401 (2009).","journal-title":"Am. J. Cardiol."},{"key":"29060_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","volume":"7","author":"JS Lim","year":"2010","unstructured":"Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M. & Lustig, R. H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7, 251\u2013264 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"29060_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella, G. G. et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568, 351\u2013356 (2019).","journal-title":"Nature"},{"key":"29060_CR46","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","volume":"36","author":"PM Seferovic","year":"2015","unstructured":"Seferovic, P. M. & Paulus, W. J. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur. Heart J. 36, 1718\u20131727 (2015). 1727a\u20131727c.","journal-title":"Eur. Heart J."},{"key":"29060_CR47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff, J. & Tian, R. Metabolism in cardiomyopathy: every substrate matters. Cardiovasc. Res. 113, 411\u2013421 (2017).","journal-title":"Cardiovasc. Res."},{"key":"29060_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/01.RES.73.3.424","volume":"73","author":"J Sadoshima","year":"1993","unstructured":"Sadoshima, J. & Izumo, S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ. Res. 73, 424\u2013438 (1993).","journal-title":"Circ. Res."},{"key":"29060_CR49","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","volume":"49","author":"T Inoguchi","year":"2000","unstructured":"Inoguchi, T. et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49, 1939\u20131945 (2000).","journal-title":"Diabetes"},{"key":"29060_CR50","doi-asserted-by":"publisher","first-page":"e15726","DOI":"10.1371\/journal.pone.0015726","volume":"5","author":"H Yuan","year":"2010","unstructured":"Yuan, H. et al. NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of beta-cells via JNK, p38 MAPK and p53 pathways. PLoS ONE 5, e15726 (2010).","journal-title":"PLoS ONE"},{"key":"29060_CR51","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1161\/CIRCRESAHA.112.268029","volume":"110","author":"VB Patel","year":"2012","unstructured":"Patel, V. B. et al. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II\/AT1 receptor axis. Circ. Res. 110, 1322\u20131335 (2012).","journal-title":"Circ. Res."},{"key":"29060_CR52","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.bbabio.2010.04.001","volume":"1797","author":"E Rial","year":"2010","unstructured":"Rial, E. et al. Lipotoxicity, fatty acid uncoupling and mitochondrial carrier function. Biochim. Biophys. Acta 1797, 800\u2013806 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"29060_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physrev.00013.2006","volume":"87","author":"G Kroemer","year":"2007","unstructured":"Kroemer, G., Galluzzi, L. & Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99\u2013163 (2007).","journal-title":"Physiol. Rev."},{"key":"29060_CR54","doi-asserted-by":"publisher","first-page":"ra10","DOI":"10.1126\/scisignal.2004374","volume":"7","author":"M Norton","year":"2014","unstructured":"Norton, M. et al. ROMO1 is an essential redox-dependent regulator of mitochondrial dynamics. Sci. Signal. 7, ra10 (2014).","journal-title":"Sci. Signal."},{"key":"29060_CR55","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1006\/bbrc.1998.9343","volume":"250","author":"FM Vaz","year":"1998","unstructured":"Vaz, F. M., van Gool, S., Ofman, R., Ijlst, L. & Wanders, R. J. Carnitine biosynthesis: identification of the cDNA encoding human gamma-butyrobetaine hydroxylase. Biochem. Biophys. Res. Commun. 250, 506\u2013510 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"29060_CR56","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/cvr\/cvy274","volume":"115","author":"OJ M\u00fcller","year":"2019","unstructured":"M\u00fcller, O. J. et al. Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure. Cardiovasc. Res. 115, 1296\u20131305 (2019).","journal-title":"Cardiovasc. Res."},{"key":"29060_CR57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/cvr\/cvv105","volume":"106","author":"D Abdurrachim","year":"2015","unstructured":"Abdurrachim, D. et al. Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models. Cardiovasc. Res. 106, 194\u2013205 (2015).","journal-title":"Cardiovasc. Res."},{"key":"29060_CR58","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/nm1116","volume":"10","author":"L Cheng","year":"2004","unstructured":"Cheng, L. et al. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10, 1245\u20131250 (2004).","journal-title":"Nat. Med."},{"key":"29060_CR59","doi-asserted-by":"crossref","unstructured":"Legchenko, E., et al. PPAR\u03b3 agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation. Sci. Transl. Med. 10 (2018).","DOI":"10.1126\/scitranslmed.aao0303"},{"key":"29060_CR60","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJM198012113032403","volume":"303","author":"PR Chapoy","year":"1980","unstructured":"Chapoy, P. R. et al. Systemic carnitine deficiency-a treatable inherited lipid-storage disease presenting as Reye\u2019s syndrome. N. Engl. J. Med. 303, 1389\u20131394 (1980).","journal-title":"N. Engl. J. Med."},{"key":"29060_CR61","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJM198012113032410","volume":"303","author":"J McGarry","year":"1980","unstructured":"McGarry, J. & Foster, D. Systemic carnitine deficiency. N. Engl. J. Med. 303, 1413\u20131415 (1980).","journal-title":"N. Engl. J. Med."},{"key":"29060_CR62","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1253\/circj.72.926","volume":"72","author":"T Sakurabayashi","year":"2008","unstructured":"Sakurabayashi, T. et al. L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis. Circ. J. 72, 926\u2013931 (2008).","journal-title":"Circ. J."},{"key":"29060_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.lfs.2017.12.015","volume":"194","author":"ZY Wang","year":"2018","unstructured":"Wang, Z. Y., Liu, Y. Y., Liu, G. H., Lu, H. B. & Mao, C. Y. l-Carnitine and heart disease. Life Sci. 194, 88\u201397 (2018).","journal-title":"Life Sci."},{"key":"29060_CR64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/1440-1681.13155","volume":"46","author":"M Li","year":"2019","unstructured":"Li, M. et al. The protective effects of L-carnitine on myocardial ischaemia-reperfusion injury in patients with rheumatic valvular heart disease undergoing CPB surgery are associated with the suppression of NF-\u03baB pathway and the activation of Nrf2 pathway. Clin. Exp. Pharmacol. Physiol. 46, 1001\u20131012 (2019).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"29060_CR65","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","volume":"88","author":"JJ DiNicolantonio","year":"2013","unstructured":"DiNicolantonio, J. J., Lavie, C. J., Fares, H., Menezes, A. R. & O\u2019Keefe, J. H. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin. Proc. 88, 544\u2013551 (2013).","journal-title":"Mayo Clin. Proc."},{"key":"29060_CR66","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2261-14-88","volume":"14","author":"R Shang","year":"2014","unstructured":"Shang, R., Sun, Z. & Li, H. Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis. BMC Cardiovasc. Disord. 14, 88 (2014).","journal-title":"BMC Cardiovasc. Disord."},{"key":"29060_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MOL.0000000000000036","volume":"25","author":"JM Brown","year":"2014","unstructured":"Brown, J. M. & Hazen, S. L. Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Curr. Opin. Lipidol. 25, 48\u201353 (2014).","journal-title":"Curr. Opin. Lipidol."},{"key":"29060_CR68","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3389\/fmicb.2019.02999","volume":"10","author":"C Eberl","year":"2019","unstructured":"Eberl, C. et al. Reproducible colonization of germ-free mice with the oligo-mouse-microbiota in different animal facilities. Front. Microbiol. 10, 2999 (2019).","journal-title":"Front. Microbiol."},{"key":"29060_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33018-5","volume":"8","author":"A Ramezani","year":"2018","unstructured":"Ramezani, A. et al. Gut colonization with methanogenic archaea lowers plasma trimethylamine N-oxide concentrations in apolipoprotein e-\/- mice. Sci. Rep. 8, 14752 (2018).","journal-title":"Sci. Rep."},{"key":"29060_CR70","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia, G. et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34, 2159\u20132219 (2013).","journal-title":"Eur. Heart J."},{"key":"29060_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41421-018-0058-6","volume":"4","author":"J Huang","year":"2018","unstructured":"Huang, J. et al. ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to beta-blockers in patients with heart failure. Cell Discov. 4, 57 (2018).","journal-title":"Cell Discov."},{"key":"29060_CR72","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41422-019-0190-3","volume":"29","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells. Cell Res. 29, 516\u2013532 (2019).","journal-title":"Cell Res."},{"key":"29060_CR73","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"29060_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"29060_CR75","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.chroma.2013.01.078","volume":"1292","author":"T Yamada","year":"2013","unstructured":"Yamada, T. et al. Development of a lipid profiling system using reverse-phase liquid chromatography coupled to high-resolution mass spectrometry with rapid polarity switching and an automated lipid identification software. J. Chromatogr. A 1292, 211\u2013218 (2013).","journal-title":"J. Chromatogr. A"},{"key":"29060_CR76","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.talanta.2017.09.046","volume":"178","author":"L Xu","year":"2018","unstructured":"Xu, L., Wang, X., Jiao, Y. & Liu, X. Assessment of potential false positives via orbitrap-based untargeted lipidomics from rat tissues. Talanta 178, 287\u2013293 (2018).","journal-title":"Talanta"},{"key":"29060_CR77","doi-asserted-by":"crossref","unstructured":"Li, D., et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell 17, e12768 (2018).","DOI":"10.1111\/acel.12768"},{"key":"29060_CR78","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.117.030811","volume":"138","author":"L Zhou","year":"2018","unstructured":"Zhou, L. et al. Cardioprotective role of myeloid-derived suppressor cells in heart failure. Circulation 138, 181\u2013197 (2018).","journal-title":"Circulation"},{"key":"29060_CR79","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.physbeh.2012.03.021","volume":"106","author":"CX Yi","year":"2012","unstructured":"Yi, C. X. et al. Exercise protects against high-fat diet-induced hypothalamic inflammation. Physiol. Behav. 106, 485\u2013490 (2012).","journal-title":"Physiol. Behav."},{"key":"29060_CR80","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.2337\/db13-0729","volume":"63","author":"L Liu","year":"2014","unstructured":"Liu, L. et al. Adipose-specific knockout of Seipin\/Bscl2 results in progressive lipodystrophy. Diabetes 63, 2320\u20132331 (2014).","journal-title":"Diabetes"},{"key":"29060_CR81","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1210\/me.2008-0311","volume":"23","author":"O Araki","year":"2009","unstructured":"Araki, O., Ying, H., Zhu, X. G., Willingham, M. C. & Cheng, S. Y. Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol. Endocrinol. 23, 308\u2013315 (2009).","journal-title":"Mol. Endocrinol."},{"key":"29060_CR82","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1128\/MCB.01122-06","volume":"27","author":"N Harada","year":"2007","unstructured":"Harada, N. et al. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. Mol. Cell. Biol. 27, 1881\u20131888 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"29060_CR83","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","volume":"20","author":"RA Koeth","year":"2014","unstructured":"Koeth, R. A. et al. gamma-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO. Cell Metab. 20, 799\u2013812 (2014).","journal-title":"Cell Metab."},{"key":"29060_CR84","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1172\/JCI12590","volume":"107","author":"JA Ibdah","year":"2001","unstructured":"Ibdah, J. A. et al. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J. Clin. Invest. 107, 1403\u20131409 (2001).","journal-title":"J. Clin. Invest."},{"key":"29060_CR85","doi-asserted-by":"publisher","first-page":"e009289","DOI":"10.1161\/JAHA.118.009289","volume":"7","author":"S Alam","year":"2018","unstructured":"Alam, S. et al. Aberrant mitochondrial fission is maladaptive in desmin mutation\u2013induced cardiac proteotoxicity. J. Am. Heart Assoc. 7, e009289 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"29060_CR86","doi-asserted-by":"publisher","first-page":"e21746","DOI":"10.1371\/journal.pone.0021746","volume":"6","author":"GW Rogers","year":"2011","unstructured":"Rogers, G. W. et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS ONE 6, e21746 (2011).","journal-title":"PLoS ONE"},{"key":"29060_CR87","first-page":"931","volume":"51","author":"YY Weng","year":"2016","unstructured":"Weng, Y. Y. et al. Establishment and application of cell models with stable expression of hOCTN1\/2. Yao Xue Xue Bao 51, 931\u2013937 (2016).","journal-title":"Yao Xue Xue Bao"},{"key":"29060_CR88","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.toxlet.2019.08.013","volume":"316","author":"T Jiang","year":"2019","unstructured":"Jiang, T. et al. Up-regulation of hepatic fatty acid transporters and inhibition\/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis. Toxicol. Lett. 316, 183\u2013193 (2019).","journal-title":"Toxicol. Lett."},{"key":"29060_CR89","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.031139","volume":"137","author":"L Zhang","year":"2018","unstructured":"Zhang, L., et al. Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases. Circulation 137, 1374-1390 (2018).","journal-title":"Circulation"},{"key":"29060_CR90","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm1327","volume":"12","author":"M Hayashi","year":"2006","unstructured":"Hayashi, M. et al. A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy. Nat. Med. 12, 128\u2013132 (2006).","journal-title":"Nat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29060-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:53:09Z","timestamp":1669308789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29060-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["29060"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-29060-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1757"}}